Oxygen Biotherapeutics Inc (NASDAQ:TENX)

CAPS Rating: 1 out of 5

TENX News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

23 Outperform
35 Underperform
 

All-Star Players

3 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top TENX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.83)
Submitted December 14, 2010

It's rather difficult to get to the bottom of what Oxygen Biotherapeutics is doing. They appear to be developing various forms of a perfluorocarbon oxygen carrier intended for use in traumatic brain injury, shock, decompression sickness, and wound… More

zzlangerhans (99.83)
Submitted October 18, 2013

After years of futility attempting to develop their synthetic oxygen-carrying compound Oxycyte, Oxygen has finally successfully commercialized a product. It's called preferred stock, and they've been selling tons of it lately. Their follow-on… More

TENX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about TENX.

Recs

0
Member Avatar stubbo (< 20) Submitted: 1/3/2014 7:13:26 PM : Outperform Start Price: $5.74 TENX Score: -132.12

The product of theirs to watch is Oxycyte. Half way through phase 2b trials in EU and Israel. This stuff is a game changer for those with traumatic brain injury and stroke.

Recs

0
Member Avatar SaintCrouton (< 20) Submitted: 10/30/2013 2:09:31 PM : Outperform Start Price: $2.28 TENX Score: -125.59

Levosimendan

Recs

5
Member Avatar zzlangerhans (99.83) Submitted: 10/18/2013 4:51:27 PM : Underperform Start Price: $1.44 TENX Score: +115.85

After years of futility attempting to develop their synthetic oxygen-carrying compound Oxycyte, Oxygen has finally successfully commercialized a product. It's called preferred stock, and they've been selling tons of it lately. Their follow-on product, warrants, has also been doing well. Of course, selling those products doesn't do wonders for the share count or the stock price but there's a cure for that too - a reverse split. Now the stock is at 1.5 again and there's just a couple million shares with no one the wiser, except the old shareholders who have a twentieth of the shares that they had the last time the stock was at 1.5.

It will be interesting to see which way Oxygen chooses to go at this point. One choice would be the old low-float pop on some manufactured catalyst or phony sellside buy rating. I remember Rosetta Genomics had some fun with that one not too long ago. I'm just happy to get Oxygen back into CAPS, as I had thought them lost forever after their last disappearance below the 50 cent threshold. Thank god for reverse splits.

Leaderboard

Find the members with the highest scoring picks in TENX.

Score Leader

HDTVBG

HDTVBG (< 20) Score: +258.61

The Score Leader is the player with the highest score across all their picks in TENX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
str8nuts < 20 2/1/2010 Underperform 3W $5.73 -91.97% +137.73% +229.71 0 Comment
snakeyd < 20 3/3/2010 Underperform 1Y $5.00 -90.80% +128.56% +219.36 0 Comment
dgu004 93.17 1/6/2010 Underperform 5Y $5.20 -91.15% +126.21% +217.36 0 Comment
SneakyPete21 < 20 1/6/2010 Underperform 5Y $5.18 -91.12% +125.91% +217.03 0 Comment
jbrevelations 45.31 3/29/2010 Underperform 1Y $6.25 -92.64% +119.02% +211.66 0 Comment
rodsoares 72.98 3/30/2010 Underperform 5Y $5.79 -92.06% +118.89% +210.95 0 Comment
jhbarr 70.52 3/30/2010 Underperform 5Y $5.31 -91.34% +119.60% +210.94 0 Comment
internettrash < 20 3/17/2010 Underperform 5Y $5.00 -90.80% +119.77% +210.57 0 Comment
pharmacy1985 70.86 4/5/2010 Underperform 5Y $4.75 -90.31% +116.93% +207.25 0 Comment
foolstracker < 20 4/7/2010 Underperform 5Y $4.80 -90.42% +116.42% +206.84 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for TENX.

Featured Broker Partners